The share capital of IGEA Pharma N.V. comprises 25,048,769 shares with a nominal value of EUR 0.01 each. The opening price was CHF 3.75 per share, corresponding to a market capitalization of around CHF 94 million. An offering of the company’s shares has not taken place.

IGEA Pharma N.V. is a life sciences company with its corporate headquarters in Amsterdam in the Netherlands. The IGEA Group focuses on products and services related to the prevention of Alzheimer's and Type II Diabetes. For more information on the company, please visit: www.igeapharma.nl


Any questions?

Please do not hesitate to contact Julian Chan.

 
About SIX
SIX operates and develops infrastructure services for the Swiss and Spanish Stock Exchanges, for Post-Trade Services, Banking Services and Financial Information with the aim of raising efficiency, quality and innovative capacity across the entire value chain of the Swiss and Spanish financial centers. The company is owned by its users (120 banks). With a workforce of 3,685 employees and a presence in 20 countries, it generated operating income of CHF 1.5 billion and Group net profit of CHF 73.5 million in 2021.
www.six-group.com